Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-23-000006

Chief Commercial Officer sold 2,400 shares at $20.05 ($48,120)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mottiwala Aziz · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-07-19 Sale : show line 1 in the form 10b5-1 −2,400 $20.05 $48,120 45,806 D
Open-market sales · 2,400 sh · avg $20.05 · $48,120
Loading xslF345X05/wk-form4_1689976000.xml…